According to the official website of the U.S. Food and Drug Administration (FDA), on November 30, the FDA conducted a scientific review of the risk modification application update submitted by the U.S. subsidiary of Swedish Match, a match company.
The FDA stated that the validity of the Risk Modification Order is five years from the date of issuance. If the company wishes to continue selling risk-modified products, they will need to submit an updated application to the FDA to confirm that the product still meets the requirements of the 911 provisions. The updated application can refer to the original risk modification application and include the Pre-Market Tobacco Application (PMTA) and Modified Risk Tobacco Product (MRTP) annual reports submitted based on market demand.
On October 22nd, 2019, the FDA issued a regulatory adjustment order to the US subsidiary of Swedish Match Company (formerly known as Swedish Match North America Inc) regarding the following smokeless tobacco products:
General bulk; General dry mint pocket mini original flavor; General pocket large original flavor; General classic pocket white large-12 packs; General mint pocket white large; General Nordic mint pocket white large-12 packs; General pocket white large; General holly pocket white large, etc. The annual report of MRTP needs to include the cumulative results of post-market monitoring and research conducted by all companies that have been granted risk-adjusted status. Once all updated application materials for MRTP are released, the FDA will announce the end date of the comment period, which shall be at least 180 days after the first release of the application materials, and at least 30 days after the last release of the application materials.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
